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Abstract
Cannabis (hemp and marijuana) is an iconic yet controversial crop. On the one hand, it rep-
resents a growing market for pharmaceutical and agricultural sectors. On the other hand,
plants synthesizing the psychoactive THC produce the most widespread illicit drug in the
world. Yet, the difficulty to reliably distinguish between Cannabis varieties based on morpho-
logical or biochemical criteria impedes the development of promising industrial programs
and hinders the fight against narcotrafficking. Genetics offers an appropriate alternative to
characterize drug vs. non-drug Cannabis. However, forensic applications require rapid and
affordable genotyping of informative and reliable molecular markers for which a broad-scale
reference database, representing both intra- and inter-variety variation, is available. Here
we provide such a resource for Cannabis, by genotyping 13 microsatellite loci (STRs) in 1
324 samples selected specifically for fibre (24 hemp varieties) and drug (15 marijuana varie-
ties) production. We showed that these loci are sufficient to capture most of the genome-
wide diversity patterns recently revealed by NGS data. We recovered strong genetic struc-
ture between marijuana and hemp and demonstrated that anonymous samples can be con-
fidently assigned to either plant types. Fibres appear genetically homogeneous whereas
drugs show low (often clonal) diversity within varieties, but very high genetic differentiation
between them, likely resulting from breeding practices. Based on an additional test dataset
including samples from 41 local police seizures, we showed that the genetic signature of
marijuana cultivars could be used to trace crime scene evidence. To date, our study pro-
vides the most comprehensive genetic resource for Cannabis forensics worldwide.
Introduction
Cannabis is one of humanity’s oldest cultivated plant. It is thought to have originated in central
Asia and was domesticated as early as 8 000 BP for food, fibre, oil, medicines and as an inebri-
ant. This crop was since distributed across the world during the last two millennia and, due to
its recent legalization in several countries, is increasingly exploited by several industrial sectors
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(hemp) and as a recreational drug (marijuana). The taxonomic status of Cannabis has always
been disputed, as it encompasses multiple cultural, geographic, historical and functional
aspects (reviewed in [1–4]). Whereas most authors now consider it a monotypic panmictic
taxon, Cannabis sativa, three species or subspecies (sativa, indica and ruderalis) are often men-
tioned but without a comprehensive taxonomic grouping so far. The nomenclature may thus
differ depending on whether it refers to morphological or chemical variation, geographic dis-
tribution, ecotype, as well as crop-use characteristics and intoxicant properties resulting from
human selection [4–7]. Cannabis presumably diversified following selection for traits enhanc-
ing fibre and seed production (”hemp”) or psychoactive properties ("drug"). Importantly, Can-
nabis types differ in their absolute and relative amounts of terpenophenolic cannabinoids,
notably Δ1-tetrahydrocannabinol (THC), the well-known psychoactive compound of mari-
juana, and the non-psychoactive cannabidiol (CBD). In this context, drug-type Cannabis
(marijuana) is broadly characterized by a higher overall cannabinoid content than fibre-types.
However, the most widely recognized criteria to assign a Cannabis plant to either “drug” or
“hemp” type is the THC:CBD ratio, according to which three main chemical phenotype (che-
motype) classes are recognized: hemp-type plants with a low ratio (THC:CBD < 1), drug-type
plants with a high ratio (THC:CBD > 1), and intermediate-type plants with a ratio close to
one [6, 8]. The informal designation sativa and indica may have various, controversial mean-
ings. Morphologically, the name sativa designates tall plants with narrow leaves, while indica
refers to short plants with wide leaves. Among the marijuana community however, sativa
rather refers to equatorial varieties producing stimulating psychoactive effects (THC:CBD
1), whereas indica-type plants from Central Asia are used for relaxing and sedative drugs
(THC:CBD > 1) [8].
The commercial interest for Cannabis has declined during the XXth century due e.g. to the
development of synthetic fibres and the stringent policies regarding its exploitation, but this
iconic weed is recently regaining attention in many countries for its high medicinal, industrial
and agricultural potentials (reviewed in [9]). However, its usage is still controversial, in partic-
ular from agro-economic, public health and forensic perspectives. Due to its intoxicant prop-
erties, the cultivation and possession of Cannabis is under strict legal regulations. High-THC:
CBD varieties are prohibited in many countries but remain the most frequently-used illicit
drug worldwide [10] (~180 million consumers in 2013, [11]), in the form of marijuana (dried
inflorescences) or hashish (resin). In contrast, low-THC:CBD hemp crops can be exploited
under licensed control for seed oil, fibres and pharmaceutical industries. For instance, quanti-
tative measures of THC-content are currently considered by the EU for approval as a licensed
hemp cultivar (below 0.2% THC weight per weight in the mature dry inflorescences; http://ec.
europa.eu/food/plant_en). Yet, hemp and marijuana varieties are hardly distinguishable mor-
phologically and discrimination of drug vs. non-drug chemotypes by quantitative THC-dosage
has also proven inadequate due to its dependence on environmental factors, to the strong varia-
tion during the plant’s life cycle, as well as between individual plants [12–13]. In addition, the
qualitative assessment of THC:CBD ratio is also problematic for an unequivocal discrimination
between fibre and drug types, due to the presence of a largely variable intermediate chemotype
class, the occurrence of several exceptions (e.g. hemp accessions with a THC-predominant che-
motype; [14–16]) and the common practice among drug breeders to produce hybrid varieties.
This issue largely impedes crops’ improvement and full-scale industrial development; it
even causes a security risk, as licensed crops may be used as a cover for illegal drug production.
Moreover, it significantly limits the ability of law-enforcement agencies to trace drug seizures
and link illegal producers to organized crime syndicates supplying the black market of Canna-
bis drugs. In addition, Cannabis can have long-distance dispersal capabilities [17], and fibre
crops might face cryptic contamination by pollen from drug varieties.
Forensic Genetics of Cannabis
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Genetic tools offer a promising avenue to overcome these issues, especially to distinguish
between drug vs. non-drug plants [18]. Importantly, genetics requires small amounts of tissues
as a DNA source, whereas chemical analyses necessitate inflorescences. A promising aspect
has been to genotype loci directly linked to THC synthesis [8, 19] in association with chemo-
type profiling. However, this association is not ubiquitous [14–15], and genotyping may be
compromised by complex gene duplications, pseudogenes [20–22] and, that only a limited
number of varieties among the tremendous Cannabis diversity has been validated [15]; more-
over, chemotype seem to greatly vary even among genotypes [20].
A parallel, complementary approach is to discriminate drug vs. hemp plants from their non-
adaptive genetic variation. Until the recent past, the genetic diversity of Cannabis has remained
surprisingly under-investigated, partly due to the important restrictions imposed by anti-drug
policies, even for scientific inquiries. In the last few years, a draft genome of Cannabis was pub-
lished [22] and high-density Single-Nucleotide-Polymorphism (SNP) data obtained from Next-
Generation-Sequencing (NGS) techniques evidenced genome-wide differentiation between
hemp and marijuana plants [23]. However, genetic resources applicable for forensics remain
under-developed. Forensic investigations require sets of sufficiently informative loci that can be
genotyped in large batches of samples in a rapid and affordable manner, such as microsatellites
(Short-Tandem-Repeats, STRs). Another prerequisite is that the species’ diversity is exhaustively
represented in reference databases, both within and among varieties, so that investigated samples
of unknown origin can be identified with statistical confidence. In Cannabis, these two aspects
are challenging given the diversity of varieties, their complex breeding histories, as well as the
rapid shifts of the drug varieties available on black markets. In addition, hemp and marijuana
diverged during the human era and still largely share a common pool of genetic variation [23].
Several microsatellite analyses were previously performed on Cannabis. Some loci became
available in the early 2000s [24–26] but remained scarcely tested at the individual or popula-
tion level. The first STR multiplex kit for forensics was validated years later [27], and subse-
quently trialed to distinguish fibres from confiscated drug seizures in Australia, with moderate
success [28]. Another STR kit was developed by Ko¨hnemann et al. [29], although without ref-
erence data. Using transcriptomic sequences (EST), Gao et al. [30] isolated >100 STRs, allow-
ing them to discriminate between Chinese and European hemp samples according to their
geographic origin. Other studies genotyped Cannabis, notably from police seizures, using new
or published markers [31–35]. However, although these studies are regionally and timely rele-
vant, they rely on limited sample sets (i.e. few varieties and few individuals per variety, and/or
only representing plants available on a regional black market at the time of confiscations), thus
hardly accounting for the different levels of genetic variation of Cannabis stocks. So far no
comprehensive database of Cannabis diversity exists for broad-scale forensic enquiries.
Considering these limitations, we developed a new STR resource for Cannabis forensics.
We analyzed intra- and inter-populational variation at 13 published STRs markers in>1 300
Cannabis samples from 48 fibre and drug accessions, broadly representative of known hemp
and marijuana varieties (S1 Table), and characterized unknown samples of various origins,
notably police seizures. We aimed at (i) showing that these loci fully recover the genetic struc-
ture between marijuana and hemp; (ii) demonstrating that anonymous samples can be confi-
dently assigned to either plant types; and (iii) documenting the genetic diversity among and
within samples and its potential for forensic investigations.
Results and Discussion
The selected STR markers (detailed in S2 Table) unanimously recovered the strong structure
between fibres and drug Cannabis samples. This is clearly depicted by a Principal Component
Forensic Genetics of Cannabis
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Analysis (PCA, Fig 1A), genetic distances between accessions (Fst, S1 Fig) and genotype clus-
tering by STRUCTURE (Fig 1B), where two groups appears as the best clustering solution
(ΔK2 = 1205.6). As recently evidenced from NGS data [23], this pattern reflects differentiation
between hemp and marijuana over the entire genome, not only at genes underlying THC and
fibre synthesis. Some drugs and fibres show weak signs of genetic admixture (intermediate
PCA scores and STRUCTURE probabilities, Fig 1; lower Fst, S1 Fig), which might stem from
introgressive crossbreeding, as reported elsewhere [23]. Interestingly, except for RI (indica/
ruderalis hybrid), all drug varieties closely-related to hemps are of sativa ancestry (HMW, HA,
SWA, MS; based on available information from suppliers). This would support the common
assumption that hemp varieties selected for fibre and seed production derived from sativa,
although this view has been challenged by other studies that found more similarities between
hemp and indica [7, 23, 36]. Alternatively, sativa drugs, which are nowadays distributed in
more equatorial regions, may be frequently crossbred with indica and agricultural varieties to
facilitate their cultivation in temperate countries. In any case, marijuana genetic diversity
seems weakly associated with the documented breeding history: we also performed a PCA
solely on drugs, which only marginally clustered according to their main sativa and indica ped-
igree (S2 Fig). Some cultivars of the same appellation appear genetically distinct (e.g. Alpine
Rocket, ARa and ARb, FST = 0.36) whereas others harboring different names are genetically
identical (e.g. PM, T44, BS, FST = 0.00; identical clones shared by ARa and B52, S1 Table).
Overall, these observations are in line with the general conclusions of Sawler et al. [23] that
drug varieties are often misinformed due to the clandestine nature of Cannabis breeding over
the last century, and that names do not necessarily reflect a meaningful genetic identity. In
addition, hemp varieties grouped according to reproductive characteristics, as expected (dioe-
cious versus monoecious; S1 Table), as a result of their breeding history (illustrated on the
PCA, Fig 1; Fst tree, S1 Fig).
Intra-variety diversity was relatively similar among hemps (Fig 2). Allelic richness (average
number of alleles per population AR, scaled to eight individuals) and heterozygosity (HO) aver-
aged 4.0 ± 0.8 and 0.59 ± 0.10 respectively (Fig 2). All varieties had positive inbreeding coeffi-
cients (FIS = 0.19 ± 0.05), potentially reflecting bottlenecks linked to current breeding
practices. The overall differentiation among hemps was relatively low (FST = 0.15 ± 0.07; S1
Fig). In contrast, marijuana featured lower diversity within varieties (AR = 2.3 ± 0.9, HO =
0.41 ± 0.15; Fig 2) but substantially higher genetic distances among them (FST = 0.39 ± 0.16; S1
Fig). We detected identical genotypes (clones) and strong excess of heterozygosity among sev-
eral breeds (all of indica or mixed origin, S1 Table), which translates into AR of 2, HO of 0.5
and FIS reaching -1 (Fig 2), resulting from clonal breeding from hybrids of two different paren-
tal strains. Interestingly, sativa drugs featured more hemp-like patterns of diversity. Overall,
the homogeneous gene pool of hemps suggests more frequent crossbreeding compared to
drugs [23], especially of indica content, and/or that a wider genetic base has been sourced by
the hemp industry. Marijuana is often propagated clonally for practical reasons as well as to
protect the genetic identity of varieties from contamination by wind-dispersing pollens, thus
reducing diversity and triggering strong heterozygosity in F1 cross-breeds. Moreover, all Can-
nabis drug forms are dioecious, and males, which produce lower amounts of THC than
females, are discarded by breeders, which further reduces diversity.
The diversity captured by our STR markers appears well representative of the genomic
background of Cannabis: our results are overall very concordant with high-density SNP data
[23]. Our STR database thus seems appropriate for broad-scale forensic applications, in partic-
ular to discriminate between drug vs. non-drug samples, one of the main task of Cannabis
forensics. To demonstrate this ability, we performed genetic assignment tests (direct or resam-
pling-based) on random subsets of drug and fibre samples, using the remainder of the dataset
Forensic Genetics of Cannabis
PLOS ONE | DOI:10.1371/journal.pone.0170522 January 20, 2017 4 / 13
Forensic Genetics of Cannabis
PLOS ONE | DOI:10.1371/journal.pone.0170522 January 20, 2017 5 / 13
as reference (detailed in the Methods section). The direct test always correctly assigned every
sample to their plant type (Table 1). The more conservative resampling approach never misas-
signed any specimen (Table 1). Many individuals are yet not assigned to any group (even the
correct one) because genotypes are considered not statistically informative enough by this con-
servative analysis. We further evaluated the database by genotyping 340 additional Cannabis
samples of various origins (bird food, drug and fibre specimens, uncertain industrial cultivars
and police seizures). Known specimens (n = 8) were all correctly assigned with high confi-
dence (Table 2). All but one industrial cultivars (n = 37) consisted of hemps, with few getting
assignment probabilities below 0.95 (Table 2). Confiscated samples (n = 295, from 41 different
seizures) could be unambiguously assigned except for three specimens (Table 2).
These results clearly illustrate the relevance of our new database for forensics. Notably, it
outperforms the reference published by Howard et al. [28] for Australian seizures, which suf-
fered substantial mis-assignment risks, but yet so far was the only available resource properly
tested by statistical assignments. Moreover, compared to previous studies, our sampling
scheme has the advantage of covering a broad range of Cannabis varieties and accounts for
their intra-variety variation. The latter seems important to consider, as some marijuana
(sativa) and hemp cultivars share closely-related gene pools, sometimes making their discrimi-
nation difficult.
In addition, the strong genetic structure between drug cultivars may provide opportunities
for police investigations of narcotrafficking. One challenge for law-enforcement agencies is to
trace evidences collected at crime scenes in order to connect and convict acting members of
crime syndicates. Most marijuana individuals/germlines show unique genetic profiles at our
markers (Fig 1A, S2 Fig), so they could be suitable for this task. We screened for identical geno-
types among the seized Western-Swiss samples of our test dataset, where the probability of iden-
tity PI-sib is 8.9 × 10−5. We could established five groups of related seizures (some even matched
by several germlines) thus with 99.991% confidence (S3 Table); the remaining 25 seizures were
genetically different (S3 Table). Given the high resolution at such narrow regional scale, this
approach could also be applied at national or international levels. The illegal trade of Cannabis
is one of the most developed illicit industries in the world (> 7 000 tons seized in 2013, [11]),
yearly generating enormous profits used to finance other criminal activities. Exploiting the
genetic heterogeneity of marijuana should be the focus of further forensic development to aid
the international fight against narcotrafficking.
To date, our STR database is the most powerful resource suitable for routine forensic analyses
of Cannabis. Yet, it remains limited by several aspects. First, drug vs. non-drug discrimination
can be ambiguous for some samples, given the lack of differentiation and/or crossbreeding prac-
tices between few hemp and marijuana varieties. Second, the plant type of our reference samples
rely on the information provided by the suppliers, which could be confirmed by chemotyping
analyses. Third, more sensitive applications such as tracing drug evidences might require a finer
resolution. In both cases, updating the database with additional markers and reference popula-
tions, especially new drug varieties, seems a worthy investment. Further development would
benefit from international collaborations. An array of genetic studies have been conducted on
Cannabis in just a few years by different research teams (see Introduction), each contributing
specific sets of samples and markers. Given the tremendous diversity of marijuana and the legal
difficulty to access samples, joint efforts between Cannabis genetics’ experts worldwide would
Fig 1. Principal Component Analysis (A) and Bayesian clustering with STRUCTURE (B) of individual genotypes from 48 Cannabis
accessions. Fibre and drug accessions are displayed in green and red respectively on the PCA. Ellipses illustrate 80% inertia of each accessions.
Dots represent individuals, linked to their accessions (labelled within colored squares). On the STRUCTURE barplots, colors show the probability of
assignment to each cluster (K = 2), perfectly distinguishing fibres from drugs.
doi:10.1371/journal.pone.0170522.g001
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Fig 2. Genetic diversity within each Cannabis accession. FIS: inbreeding coefficient; HO: observed heterozygosity; AR: allelic richness
(scaled for 8 individuals). For drugs, main documented sativa/indica component are indicated.
doi:10.1371/journal.pone.0170522.g002
Forensic Genetics of Cannabis
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allow unprecedented opportunities to extend forensic advances and promote the development
of the industrial and therapeutic potential of this emblematic species.
Materials and Methods
Ethics statement
This study does not involve any endangered or protected species.
Sample collection
We built a collection of 1,324 Cannabis samples from 30 accessions of fibres (n = 972 from 24
different varieties) and 18 accessions of drug (n = 352 from 15 varieties). These accessions
broadly cover the legal European hemp varieties (landraces, cultivars selected from landraces
and cross-bred cultivars) and marijuana diversity (identified a priori as sativa, indica and
hybrids by breeders). In order to also capture intra-variety variation, we included large popula-
tion samples for each accession (27 samples on average, from 9 to 50). Seeds and leaves were
obtained from agronomic companies, germplasm collections, police seizures or commercial
stores; seeds were germinated at the University of Lausanne (Switzerland). S1 Table provides
sample origin and reported breeding history, given available documentation and information
provided by the suppliers.
To evaluate our reference database, we further considered 340 additional test samples from
uncertain (police seizures, industrial cultivars) or known types (fibre and drug samples not
included in the reference database). Confiscated plants (n = 295) represented 41 police seizures
across Western Switzerland from 2005 to 2010. Details are provided in S3 Table.
DNA extraction and microsatellite genotyping
DNA was extracted from approximately 25 mg of dried plant leaves using the FastDNA Kit
(Qbiogene, Carlsbad, CA) following the manufacturer’s instructions. Thirteen published
Table 1. Database auto-evaluation by assignment tests of random subsets of fibre and drug samples. Values indicate the probabilities P of assign-
ment (direct method) and inclusion to either groups (resampling method), as well as their standard deviations among replicate subsets (n = 10).
Direct method Resampling-based method
Probability of assignment to the correct group Probability of inclusion
to fibres to drugs
Fibres 1.00 ± 0.00 0.50 ± 0.03 0.0 ± 0.0
Drugs 1.00 ± 0.00 0.0 ± 0.0 0.53 ± 0.04
doi:10.1371/journal.pone.0170522.t001
Table 2. Assignment trial (direct method) of 340 test samples from known (bird food, known fibres and drugs) and unknown nature (industrial cul-
tivars and police seizure). We considered assignments “safe” where the probability of assignment P was above 0.95.
Mean probability of assignment Number of safe assignments (P > 0.95)
n to fibres to drugs
bird hemp seed 1 1.00 0.00 all
known fibres 5 1.00 0.00 all
known drugs 2 0.00 1.00 all
industrial cultivars (hemp) 36 0.99 0.01 33 (92%)
industrial cultivars (marijuana) 1 0.00 1.00 all
police seizures (hemp) 13 0.99 0.01 all
police seizures (marijuana) 282 0.00 1.00 279 (99%)
doi:10.1371/journal.pone.0170522.t002
Forensic Genetics of Cannabis
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microsatellite loci were analyzed [24–25], including the ten from Howard et al.’s forensically
validated kit [28]. DNA amplifications were performed according to their STR multiplex sys-
tem (M1 and M4), slightly modified to include ANUCS202 to multiplex M4. In addition, we
integrated a new multiplex M5 to amplify loci ANUCS201 and H09-CANN2. Detailed infor-
mation on markers and multiplexes are available in S2 Table. PCR conditions were as follows:
95˚C for 5 min (initial denaturation); 10 cycles consisting of 30”at 95˚C, 30” at 66˚C down to
54˚C (-3˚C/2 cycles) and 45” at 72˚C (top-down PCR); 30 regular PCR cycles consisting of 30”
at 95˚C, 30” at 50˚C and 45” at 72˚C; 90”at 72˚C (final elongation). Amplicons were run on an
ABI PRISM 3130 Genetic Analyzer (Applied Biosystems) and genotyped were scored using
GeneMapper v3.2 (ABI).
Population genetic analyses
We analyzed the genetic structure and diversity of Cannabis by three different approaches.
First, we performed a Principal Component Analysis (PCA) on individual genotypes using the
R packages ade4 and adegenet [37]. Second we conducted Bayesian clustering of genotypes
into groups with STRUCTURE [38]. We used the admixture model without prior on sample
origin, and tested from 1 to 11 groups (K), with 10 replicates per K. Each run consisted of
100’000 iterative steps following a burn-in of 10’000. We applied the Evanno method [39] to
determine the most likely number of groups summarizing the data, as implemented in
STRUCTURE HARVESTER [40]. Replicates were combined using CLUMPP [41] and graphi-
cal displays of admixture proportions (barplots) were built with DISTRUCT [42]. Third, we
conducted population-based analyses with FSTAT [43], by calculating pairwise genetic dis-
tances between accessions (FST) as well as the following diversity indices for each accession:
observed heterozygosity (HO), inbreeding coefficient (FIS) and allelic richness (AR, scaled to 8
individuals).
Genotype specificity and assignment tests
We used GenAlEx 6 [44] to compute, within and among accessions, the number of private
alleles (PA) and probabilities of identity (PI), i.e. the probability to have identical genotypes by
chance. For the latter, we considered the conservative estimate of PI-sib when the data poten-
tially includes siblings, as appropriate for Cannabis samples. We also used GenAlEx to match
identical genotypes, notably to identify clones (function “match”).
To assess the power of discrimination between hemp and drug types, assignment analyses
were performed with GeneClass2 [45]. First, we auto-evaluated our database by assigning ten
re-sampled random subsets (representing about 10% of the total dataset, n = 100 for fibres,
n = 40 for drugs) using the rest of the data as reference. To this end, two different methods pro-
posed by the software were applied, using Bayesian criteria [46]. The first approach (direct
method) estimates the proportion of correctly assigned samples to the most likely population
of origin. The second approach (resampling-based method) computes the probability that
samples belong to each reference population, and aims at minimizing the risk of mis-assign-
ment, i.e. when individuals feature genotypes that can occur in the “wrong” reference popula-
tion (type I error). This was achieved by simulating the likelihood distribution of 10,000
independent genotypes, for each reference population (with a Monte-Carlo resampling algo-
rithm, [47]), against which the genotypes to assign can then be compared. Rejection or inclu-
sion is then decided upon a threshold (P< 0.01). This approach does not assume that all
source populations have been sampled. Second, we assigned (direct method), our 340 test sam-
ples, which consist mostly of unknown varieties.
Forensic Genetics of Cannabis
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Supporting Information
S1 Fig. Tree of genetic distances (pairwise Fst) between Cannabis accessions. Monoecious
hemp are highlighted in grey.
(TIF)
S2 Fig. Genetic structure among marijuana samples.
(TIF)
S1 Table. List and details on the Cannabis accessions.
(XLSX)
S2 Table. List and details on the STRs markers.
(XLSX)
S3 Table. List and details on test samples.
(XLSX)
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